Allergan’s profit falls 58% as recession slows Botox sales

Allergan Inc., maker of the wrinkle-smoother Botox, reported Friday that its first-quarter profit fell 58% as the recession slowed sales of eye and beauty products.

Net income dropped to $45 million, or 15 cents a share, from $108 million, or 35 cents, a year earlier, the Irvine company said. Profit excluding some items was 55 cents a share, beating by 2 cents the average analyst estimate.

Read full article via  Los Angeles Times.

Short URL: http://www.plasticsurgeonsnews.com/?p=225

Posted by admin on May 2 2009. Filed under Body Procedures, Injectables. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry